E2 ModeratePreliminaryPEM not requiredCross-SectionalPeer-reviewedReviewed
Standard · 3 min
Analysis of 16S rRNA gene sequences and circulating cell-free DNA from plasma of chronic fatigue syndrome and non-fatigued subjects.
Vernon, Suzanne D, Shukla, Sanjay K, Conradt, Jennifer et al. · BMC microbiology · 2002 · DOI
Quick Summary
Researchers tested whether bacteria in the bloodstream might be linked to ME/CFS by analyzing blood samples from people with ME/CFS and healthy controls. They found that healthy people had more detectable bacterial DNA in their blood than ME/CFS patients did, and no unique or unusual bacteria were found in either group. This suggests that a specific bacterial infection is unlikely to be a primary cause of ME/CFS.
Why It Matters
This study directly addressed whether a hidden bacterial infection might explain ME/CFS symptoms. The results help rule out a straightforward bacterial infection model, redirecting research toward understanding why ME/CFS patients show different plasma DNA patterns and encouraging investigation of other potential mechanisms.
Observed Findings
Bacterial 16S rDNA sequences were detected in 14% (4/34) of CFS subjects versus 32% (17/55) of non-fatigued controls (p=0.03).
Non-fatigued subjects had higher average plasma DNA concentrations (151 ng) than CFS subjects (91 ng), though not statistically significant.
All but one subject with detectable bacterial DNA had five or more unique bacterial sequences present.
Bacterial sequences were diverse and non-specific in both CFS and control groups, with no unique or previously uncharacterized sequences identified.
Inferred Conclusions
A single, predominant bacterial pathogen does not appear to be associated with CFS.
The diverse, non-specific nature of bacterial DNA in plasma of both groups suggests contamination or normal background rather than targeted infection.
CFS subjects show lower rates of detectable circulating bacterial DNA compared to healthy controls, contrary to an active systemic bacterial infection hypothesis.
Remaining Questions
Why do CFS subjects have lower detectable bacterial DNA in plasma compared to controls, and what does this difference mean mechanistically?
Could altered host immune responses or microbial dysbiosis in tissues (rather than bloodborne pathogens) contribute to ME/CFS?
What This Study Does Not Prove
This study does not prove bacteria are completely uninvolved in ME/CFS—it only shows that a single dominant bacterial pathogen in the bloodstream is unlikely. The cross-sectional design cannot establish causation, and the diverse bacterial sequences detected may still reflect disease-related changes rather than causal agents. The absence of a 'unique' pathogen does not exclude roles for altered microbial communities or dysbiosis.
Tags
Symptom:Fatigue
Biomarker:Blood Biomarker
Phenotype:Infection-Triggered
Method Flag:PEM Not DefinedWeak Case DefinitionSmall SampleExploratory Only
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.